OCC 1.23% 40.0¢ orthocell limited

Ann: US Nerve Repair Study Design Meets FDA Requirements, page-22

  1. 600 Posts.
    lightbulb Created with Sketch. 60
    ok thanks for that. sometimes it gets a bit confusing who the mature and serious investors with this stock are, thus who to take seriously. My gut has faith in the long run for OCC, perhaps others are disappointed as they may be day traders/short term holders. All the news is pointing to a positive future also
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.